Your browser doesn't support javascript.
loading
Variations in Textbook Oncologic Outcomes After Curative-Intent Resection: Early Versus Intermediate Hepatocellular Carcinoma Based on Barcelona Clinic Liver Cancer Criteria and Child-Pugh Classification.
Moazzam, Zorays; Alaimo, Laura; Endo, Yutaka; Lima, Henrique A; Shaikh, Chanza F; Ratti, Francesca; Marques, Hugo P; Cauchy, François; Lam, Vincent; Poultsides, George A; Popescu, Irinel; Alexandrescu, Sorin; Martel, Guillaume; Guglielmi, Alfredo; Hugh, Tom; Aldrighetti, Luca; Endo, Itaru; Pawlik, Timothy M.
Afiliación
  • Moazzam Z; Department of Surgery, The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Alaimo L; Department of Surgery, The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Endo Y; Department of Surgery, University of Verona, Verona, Italy.
  • Lima HA; Department of Surgery, The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Shaikh CF; Department of Surgery, The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Ratti F; Department of Surgery, The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, OH, USA.
  • Marques HP; Department of Surgery, Ospedale San Raffaele, Milan, Italy.
  • Cauchy F; Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
  • Lam V; Department of Hepatibiliopancreatic Surgery, APHP, Beaujon Hospital, Clichy, France.
  • Poultsides GA; Department of Surgery, Westmead Hospital, Sydney, NSW, Australia.
  • Popescu I; Department of Surgery, Stanford University, Stanford, CA, USA.
  • Alexandrescu S; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
  • Martel G; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
  • Guglielmi A; Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
  • Hugh T; Department of Surgery, University of Verona, Verona, Italy.
  • Aldrighetti L; Department of Surgery, School of Medicine, The University of Sydney, Sydney, NSW, Australia.
  • Endo I; Department of Surgery, Ospedale San Raffaele, Milan, Italy.
  • Pawlik TM; Yokohama City University School of Medicine, Yokohama, Japan.
Ann Surg Oncol ; 30(2): 750-759, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36404380
ABSTRACT

BACKGROUND:

The impact of early versus intermediate hepatocellular carcinoma (HCC) on short-term "optimal" outcomes remains ill-defined. This study sought to define the incidence of textbook oncologic outcomes (TOO), as well as to identify factors associated with TOO among patients with early versus intermediate HCC.

METHODS:

Patients who underwent curative-intent liver resection for HCC (1998-2020) were identified from a multi-institutional database. Textbook oncologic outcome (TOO) was defined as negative surgical margins, no return to the operating room, no extended hospital stay, no severe complications, and no 90-day mortality or readmission. Patients were stratified as early HCC (BCLC 0 or BCLC A/Child-Pugh A) or intermediate HCC (BCLC A/Child-Pugh B or BCLC B). Multivariate logistic regression analysis was used to assess factors associated with TOO.

RESULTS:

Among 1383 patients, the overall incidence of TOO was 69.0%. Patients with intermediate HCC were less likely to achieve a TOO (early [71.6 %] vs. intermediate [60.1%]; p < 0.001). On multivariate analysis, factors associated with decreased odds of a TOO were high tumor burden (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.33-1.00), high aspartate transaminase-platelet ratio index (APRI) (OR, 0.46; 95% CI, 0.30-0.70), Charlson Comorbidity Index (CCI) greater than 3 (OR, 0.67; 95% CI, 0.49-0.91), major liver resection (OR, 0.68; 95% CI, 0.52-0.90), and intermediate HCC (OR, 0.68; 95% CI, 0.50-0.93) (all p < 0.05). Notably, although high APRI, CCI greater than 3, and major liver resection contributed to lower odds of a TOO in early HCC, the only factor that adversely impacted TOO in intermediate HCC was high tumor burden.

CONCLUSIONS:

Patients with intermediate HCC and early HCC patients with liver dysfunction, comorbidities, or an extensive resection were less likely to achieve an "optimal" postoperative outcome.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos